Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

2 Top Artificial Intelligence (AI) Stocks to Buy Now and Hold for the Next DecadeBild von Steve Bidmead auf Pixabay : https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
2 Top Artificial Intelligence (AI) Stocks to Buy Now and Hold for the Next Decade

If want to learn how to stake your claim on the coming AI gold rush, you've come to the right place. Here are two pioneering businesses that are set to deliver bountiful artificial

The Unfortunate Truth About Maxing Out Your 401(k)
The Unfortunate Truth About Maxing Out Your 401(k)

If you want to retire a millionaire, your 401(k) can be incredibly useful in your quest to help you reach that goal. For 2023, people under age 50 may be able to contribute up to $22,500 to their

Where Will DigitalOcean Stock Be in 1 Year?Photo, wide shot, wide-angle lens,  Data analytics provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d1295d04-cceb-4f1c-be2b-32ca46621336.png
Where Will DigitalOcean Stock Be in 1 Year?

DigitalOcean's (NYSE: DOCN) stock price surged 17% on Nov. 3 after the cloud infrastructure company posted its third-quarter report. Revenue rose 16% year over year to $177 million and exceeded

1 Artificial Intelligence (AI) Stock That's a Genius Buy in November and 1 to Avoid Like the PlaguePhoto, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/12e2798a-1095-4653-8f49-2a7aee633b4e.png
1 Artificial Intelligence (AI) Stock That's a Genius Buy in November and 1 to Avoid Like the Plague

If there's one constant on Wall Street, it's that there'll always be a next-big-thing trend captivating investors' attention. Since the advent of the internet roughly 30 years ago, we've watched as

Elon Musk Called This Tesla Business a "License to Print Money" -- and Profits Could Start SoaringPhoto, wide shot, wide-angle lens, soft focus,  Auto parts supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-XjwbnkgTrFCFx6Y3gLbqZBCj.png?st=2023-05-13T09%3A21%3A52Z&se=2023-05-13T11%3A21%3A52Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T06%3A55%3A39Z&ske=2023-05-14T06%3A55%3A39Z&sks=b&skv=2021-08-06&sig=wJlbn/o%2BieTjclaQNRsJc%2BDDZieC0UCS6BPi5tapxAA%3D
Elon Musk Called This Tesla Business a "License to Print Money" -- and Profits Could Start Soaring

There's little question that Tesla (NASDAQ: TSLA) stock has been a winning investment for shareholders. So far this year, the electric vehicle (EV) maker's stock price has climbed roughly 78%, far

Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?

"Buy the dip" is a popular investing strategy, and it's an intuitive one as well.

Buying stocks on the cheap makes sense, but there's a caveat to that approach. It only works when the stock is down

This Fed Signal Has Historically Been Bad News for Stocks -- and It'll Probably Occur Again in 2024Photo, wide shot, wide-angle lens, soft focus,  Quarry, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YQuR80w6IvxjemEoWYDXbEZo.png?st=2023-10-15T10%3A03%3A37Z&se=2023-10-15T12%3A03%3A37Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-10-14T14%3A03%3A01Z&ske=2023-10-15T14%3A03%3A01Z&sks=b&skv=2021-08-06&sig=/3q45HS%2B7KQiNIRh0W63diwmt7u%2BeQQMkMTkhvmYMtE%3D
This Fed Signal Has Historically Been Bad News for Stocks -- and It'll Probably Occur Again in 2024

Over multidecade periods, fortunes are built on Wall Street. But over shorter timelines (think months or the span of a few years), the stock market is highly unpredictable.

Since the start of this

2 Monster Stocks to Buy Without Any HesitationPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
2 Monster Stocks to Buy Without Any Hesitation

While the phrase "monster stocks" might generally have investors thinking of Tesla, Apple, or similar behemoths, the two businesses discussed in this article are sneakily monstrous.

First, consumer

Here's My Top Growth Stock to Buy NowPhoto, wide shot, wide-angle lens,  Restaurant, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/6d1f34ee-79e7-4628-b30f-0a4597808d61.png
Here's My Top Growth Stock to Buy Now

Investing should be about identifying the best companies, buying their stocks, and holding them for the very long term. The key component in that equation is to identify the best companies. It's

There's 1 Month Left of Medicare Open Enrollment. Make the Most of It By Doing These ThingsPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
There's 1 Month Left of Medicare Open Enrollment. Make the Most of It By Doing These Things

The fact that Medicare enrollees get the option to make changes to their coverage annually is a good thing. Medicare plans can change from one year to the next, as can personal healthcare needs. So

2 Ultra-Safe Dividend Kings That Haven't Looked This Cheap in Years
2 Ultra-Safe Dividend Kings That Haven't Looked This Cheap in Years

The best gains in the stock market are often made by compounding wealth over time. It sounds simple, but it requires patience and perseverance in the face of volatility. Companies that are easier to

Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You?
Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You?

Superstar investor Cathie Wood doesn't flinch when she sees a declining stock price. In fact, Wood keeps her cool and often invests in struggling stocks -- as long as the particular company has a

MacroGenics (MGNX) Q3 2023 Earnings Call TranscriptPhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

MacroGenics (NASDAQ: MGNX)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Shockwave Medical (SWAV) Q3 2023 Earnings Call TranscriptPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Shockwave Medical (SWAV) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Shockwave Medical (NASDAQ: SWAV)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call TranscriptPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Vertex Pharmaceuticals (NASDAQ: VRTX)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Olo (OLO) Q3 2023 Earnings Call Transcript
Olo (OLO) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Olo (NYSE: OLO)Q3 2023 Earnings CallNov 06, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Paymentus (PAY) Q3 2023 Earnings Call Transcript
Paymentus (PAY) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Paymentus (NYSE: PAY)Q3 2023 Earnings CallNov 06, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

RingCentral (RNG) Q3 2023 Earnings Call TranscriptPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
RingCentral (RNG) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

RingCentral (NYSE: RNG)Q3 2023 Earnings CallNov 06, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Alteryx (AYX) Q3 2023 Earnings Call TranscriptPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
Alteryx (AYX) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Alteryx (NYSE: AYX)Q3 2023 Earnings CallNov 06, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Compass (COMP) Q3 2023 Earnings Call Transcript
Compass (COMP) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Compass (NYSE: COMP)Q3 2023 Earnings CallNov 06, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

TaskUs (TASK) Q3 2023 Earnings Call Transcript
TaskUs (TASK) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

TaskUs (NASDAQ: TASK)Q3 2023 Earnings CallNov 06, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Opko Health (OPK) Q3 2023 Earnings Call Transcript
Opko Health (OPK) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Opko Health (NASDAQ: OPK)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Why Altcoins Continued Their Weekend Rally on Monday
Why Altcoins Continued Their Weekend Rally on Monday

These days, we are experiencing one of those delightful periods when it seems cryptocurrencies just aren't going to obey gravity. The latest rally in such assets blasted through the weekend and into

Why Celldex Therapeutics Blasted 13% Higher on MondayPhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
Why Celldex Therapeutics Blasted 13% Higher on Monday

Clinical-stage biotech Celldex Therapeutics (NASDAQ: CLDX) was a standout on the stock market Monday. The company's share price closed a sturdy 13% higher on the day, thanks to freshly published

Why the Light Grew Dim for SunPower Stock Today
Why the Light Grew Dim for SunPower Stock Today

As the trading week kicked off on Monday, the market wasn't feeling the power of SunPower (NASDAQ: SPWR) stock. Shares of the solar company fell by more than 6%, due in no small part to a continuing